AirAsia's 800 million rupee JV with Tata group approved
NEW DELHI (Reuters) - AirAsia Bhd's (AIRA.KL) proposal to set up an airline jointly with the Tata group was approved on Wednesday by the Indian government's foreign investment regulator, paving the way for the first foreign carrier to enter the domestic aviation sector.
Malaysia's AirAsia, the largest budget carrier in Asia, plans to launch a regional airline in India with an initial investment of 800 million rupees to cash in on rising demand for domestic air travel among India's rapidly expanding middle class.
The new airline, AirAsia India, will be managed by the Malaysian company and based in the southern Indian city of Chennai.
AirAsia, through its investment arm, will own 49 percent of the new airline, with Tata Sons Ltd, the holding company of salt-to-software conglomerate Tata group, owning 30 percent. Arun Bhatia, who owns Telestra Tradeplace, an investment firm, will hold the remainder.
"It's been cleared," said Arvind Mayaram, India's economic affairs secretary, when asked about the deal. "Now they will have to take the necessary licences from the DGCA. They can start operating now once they get the licence."
The DGCA is India's aviation regulator, the Directorate General of Civil Aviation.
Earlier on Wednesday, Aviation Minister Ajit Singh said he does not expect any major hurdles for the venture.
India's aviation industry, which has been plagued by losses due to high operating costs and fierce competition, was opened to foreign investors in September last year. Foreign carriers are now able to purchase up to 49 percent of local airlines.
(Reporting by Anurag Kotoky and Rajesh Kumar Singh in NEW DELHI; Writing by Aradhana Aravindan; editing by Miral Fahmy)
- Tweet this
- Share this
- Digg this
- UPDATE 3-U.S. FDA probes cognitive impact of new cholesterol drugs
- Malaysia Airlines loses contact with plane carrying 239 people
- UPDATE 3-Boeing reports wing cracks on 787 Dreamliners in production
- UPDATE 2-White House plays down speedy role for U.S. natural gas in Ukraine
- Exclusive - Pimco's Gross declares El-Erian is 'trying to undermine me'
Drug maker Ranbaxy Laboratories Ltd has recalled more than 64,000 bottles of the generic versions of its cholesterol-lowering drug in the United States due to reports of a dose mix-up, U.S. regulators said. Full Article